News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<IPO>METiS Pharmaceuticals Considering Listing in HK, Raising US$200M: Rumor
METiS Pharmaceuticals, a Chinese company focused on the development of AI medication delivery system, is considering a Hong Kong IPO to raise up to US$200 million, Bloomberg quoted...
Reset
Send
The window will close in 5 seconds
<IPO>METiS Pharmaceuticals Considering Listing in HK, Raising US$200M: Rumor
Close
Recommend
16
Positive
25
Negative
11
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

METiS Pharmaceuticals, a Chinese company focused on the development of AI medication delivery system, is considering a Hong Kong IPO to raise up to US$200 million, Bloomberg quoted sources as saying.

It has been reported that METiS Pharmaceuticals is working with consultants on the IPO, which is likely to take place before the end of this year, with the exact scale and timing subject to change.

Related News JPM Raises MSCI Hong Kong Index Base TP to 16,500; Top Picks HKEX (00388.HK), AIA (01299.HK), TECHTRONIC IND (00669.HK), SHK PPT (00016.HK), LINK REIT (00823.HK)

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.